Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Clinical trial NCT02289144 · WITHDRAWN

Trial details

NCT number: NCT02289144
Sponsor: University of Texas Southwestern Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Anaplastic Thyroid Cancer Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer

Start date: 2015-06-01
Primary completion: 2019-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.